Drugs / T-62
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00809679 | Dec 2008 → Jun 2009 | postherpetic neuralgia | Pfizer | Terminated | No outcome recorded |
| Phase 2 | NCT00506610 | — | postherpetic neuralgia | Pfizer | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | T-62 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00506610 ↗ |